Article
Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.
Nature communications - 13 Jul 2021
Fareh Mohamed, Zhao Wei, Hu Wenxin, Casan Joshua M L, Kumar Amit, Symons Jori, Zerbato Jennifer M, Fong Danielle, Voskoboinik Ilia, Ekert Paul G, Rudraraju Rajeev, Purcell Damian F J, Lewin Sharon R, Trapani Joseph A
Abstract excerpt
The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
